The international drug conventions were created to ensure the “health and welfare of mankind”, yet drug policies around the world continue to focus on criminal justice and repression rather than on health responses. Governments across the world should provide harm reduction and treatment interventions to reduce the harms associated with drug use, and ensure adequate access to essential medicines.
The New Zealand government has come under great criticism due to a prolonged implementation of medicinal cannabis. Though the law is to be passed by March 2019, the government now anticipates a go-live date by 2020, with some arguing that this is optimistic given regulatory requirements.
In 2016, countries in Europe reported a new record high of 9,138 overdose deaths. The EMCDDA believe that through evidence-based policy making and the use of innovative solutions that can identify risk and general awareness, intervention can actually reduce overdose events and fatalities